Riskpilot← Back to searchSign inGet full accessNässjö Läkarhus AB
ABActiveOrg 5591828305Mariagatan 30General medical practice activities · NACE 8621Est. 201811 employees
Revenue 2025
SEK 21,4M
+13% vs 2024
EBITDA margin
18.2%
+10% vs 2024
Equity ratio
0.8%
Financial strength
Net profit 2025
SEK 4K
+955% vs 2024
| Revenue | SEK 21,4M | +13% |
| EBITDA | SEK 3,9M | +10% |
| Net profit | SEK 4K | +955% |
| Total assets | SEK 10M | +77% |
| Equity | SEK 85K | +5% |
| Employees | 11 | — |
Legal name
Nässjö Läkarhus AB
Org number
5591828305
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
30 november 2018
Share capital
SEK 50 000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten externa firmatecknaren
Company purpose
Föremålet för bolagets verksamhet är att bedriva vårdcentral samt därmed förenlig verksamhet.
Address
Mariagatan 30
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 19 509 | 19 253 | 19 742 | 18 970 | 21 441 |
| Staff expenses | — | — | −10 312 | −7 707 | −8 644 |
| EBITDA | 4 105 | 1 981 | 1 159 | 3 545 | 3 894 |
| Depreciation & amort. | −33 | −52 | −60 | −64 | −59 |
| EBIT | 4 072 | 1 929 | 1 099 | 3 481 | 3 835 |
| Net financials | −4 | — | −1 211 | 93 | 106 |
| Profit before tax | 19 | 18 | 358 | 29 | 41 |
| Tax | −8 | −17 | −344 | −29 | −37 |
| Net profit | 11 | 1 | 14 | 0 | 4 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 878 | 4 337 | 2 884 | 5 672 | 10 044 |
| Equity | 66 | 66 | 80 | 81 | 85 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 2 812 | 4 270 | 2 804 | 5 591 | 9 959 |
| Total debt | 2 812 | 4 270 | 2 804 | 5 591 | 9 959 |
EBITDA margin
18.2%
This company
15.8%
Market median
+15% vs market
20212025
Equity ratio
0.8%
This company
38.2%
Market median
-98% vs market
20212025
Return on equity
5.0%
This company
18.4%
Market median
-73% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
2.13×
This company
1.12×
Market median
+90% vs market
20212025
Debt / equity
117.20×
This company
0.62×
Market median
-18803% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EC Chief Auditor | Chief Auditor | 2022 |
EM External Signatory | External Signatory | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CK Klinikerna AB
Nässjö Läkarhus AB Board members of Nässjö Läkarhus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Carolina Timén | Chief Auditor | 0 companies |
| Eva Malin Lundberg | External Signatory | 0 companies |
| Aymé Pino Rodriguez | Deputy Board Member | 0 companies |
| Alejandro Carballo Palma | Board of Directors | 0 companies |